STRS Ohio
CAPR icon

STRS Ohio’s Capricor Therapeutics CAPR Stock Holding History

STRS Ohio’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$120K Buy
+12,700
New +$141K ﹤0.01% 1834

Other funds holding CAPR

Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
Black Diamond Financial
Black Diamond Financial Towson, Maryland $1.18B AUM 15.24% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return
VestGen Advisors
VestGen Advisors Inverness, Illinois $3.25B AUM 30.95% 1-Year Est. Return
NBC Securities
NBC Securities Birmingham, Alabama $1.47B AUM 20.38% 1-Year Est. Return
Activest Wealth Management
Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return
GoalVest Advisory
GoalVest Advisory New York $578M AUM 17.41% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

STRS Ohio's CAPR Position: Q3 2026 in Review

STRS Ohio opened a new position in Capricor Therapeutics (CAPR) in Q3 2026: 12,700 shares worth $120K. The stake represents ﹤0.01% of the portfolio and ranks #1834 among its holdings.

25 funds tracked by Wall St. Rank hold CAPR as of Q3 2026.

  • STRS Ohio held 12,700 shares of Capricor Therapeutics worth $120K as of Q3 2026.
  • Capricor Therapeutics was a new STRS Ohio position in Q3 2026.
  • Capricor Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q3 2026, its #1834 holding.
  • 25 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q3 2026.

Based on STRS Ohio's 13F filing for Q3 2026, filed 30 Oct 2026.